An Extension Study to Assess the Long-term Safety of the Genio® System

Not yet recruitingOBSERVATIONAL
Enrollment

39

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

July 17, 2029

Study Completion Date

July 17, 2029

Conditions
Obstructive Sleep Apnea of Adult
Interventions
DEVICE

Genio System

"All participants have previously been implanted with a Genio® system implantable stimulator. This research is observational in nature (long term safety follow-up) and participants will not be exposed to additional procedures.~The Genio System comprises of a bilateral Implantable Stimulator (IS), which is implanted via a minimally invasive surgery procedure and positioned over the genioglossus muscle with its electrodes positioned over both the left and right hypoglossal nerve branches. Stimulation of the hypoglossal nerve causes the tongue muscles to contract with the intention to maintain an open airway. The Implantable Stimulator receives energy pulses transmitted via the DP placed under the patient's chin and connected to the Activation Chip (AC), which contains the patient's stimulation parameters and contain a battery that provides energy."

Trial Locations (7)

2037

The Woolcock Institute Of Medical Research, Sydney

2145

Westmead Public Hospital, Sydney

2500

Illawarra ENT and Head & Neck Clinic, Sydney

3084

Institute for Breathing and Sleep (IBAS), Melbourne

3168

Monash Health - Department of Respiratory and Sleep Medicine, Melbourne

4000

Complete ENT, Brisbane

6009

Perth Head & Neck Surgery, Perth

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Nyxoah Pty. Ltd.

INDUSTRY

lead

Nyxoah S.A.

INDUSTRY

NCT05939141 - An Extension Study to Assess the Long-term Safety of the Genio® System | Biotech Hunter | Biotech Hunter